http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H02178262-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f7c7159366be37ecf8a4c595cfa235a8
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D205-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-06
filingDate 1988-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59f4fc4b3396a4a1c917c60c57409394
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35147596cb2b2ecd991817b9f25f9924
publicationDate 1990-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H02178262-A
titleOfInvention 1-(2'-halopropionyl)pyrrolidin-2-one derivative
abstract NEW MATERIAL:The compound of formula II (R 1 is OH-protecting group or aryl; X is halogen). n EXAMPLE: (5R)-1-(2'-bromopropionyl)-5-triphenyloxymethylpyrrolidin-2-one. n USE: A drug. A synthetic intermediate for 1-alkylcarbapenem compounds of e.g. formula I (R 2 is H or OH-protecting group) useful especially as an antibacterial agent. n PREPARATION: The objective compound of formula II is produced by reacting the compound of formula III with a protecting reagent of formula R 1 L (L is halogen or eliminable group of active ester) such as trityl chloride in an inert solvent (e.g. dichloromethane) in the presence of an acid scavenger (e.g. triethylamine or dimethylaminopyridine) and reacting the resultant compound of formula IV with a compound of formula V (Z=L) (e.g. α-bromopropionyl bromide) in a solvent (e.g. tetrahydrofuran) in the presence of a base (e.g. NaOH) at -80-+50°C. n COPYRIGHT: (C)1990,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6011150-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8841444-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5847115-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5442055-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011048583-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0597423-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0597423-A2
priorityDate 1988-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID79047
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21885
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12025
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409060395
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID235639662
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415767408
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14798
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8028
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68114197
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559095
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412224690
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419521561
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393492
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453049478
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6344
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22561186
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393434
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6456
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419531296

Total number of triples: 41.